Resultats de la cerca - Annette Paschen
- Mostrar 1 - 20 resultats de 38
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D per Anja Heinemann, Fang Zhao, Sonali Pechlivanis, Jürgen Eberle, Alexander Steinle, Sven Diederichs, Dirk Schadendorf, Annette Paschen
Publicat 2011Artigo -
5
Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events per Annette Paschen, Rosa Méndez, Pilar Jiménez, Antje Sucker, Francisco Ruíz-Cabello, Mingxia Song, Federico Garrido, Dirk Schadendorf
Publicat 2002Artigo -
6
MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells per Matthias Müller, Inken M. Beck, Judith Gadesmann, Nadine Karschuk, Annette Paschen, E. Proksch, Valentin Djonov, Karina Reiß, Radislav Sedlacek
Publicat 2010Artigo -
7
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors per Sheila López‐Cobo, Natalia Pieper, Carmen Campos‐Silva, Eva M. García‐Cuesta, Hugh T. Reyburn, Annette Paschen, Mar Valés‐Gómez
Publicat 2017Artigo -
8
Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase per Mostafa Jarahian, Carsten Watzl, Philippe Fournier, Annette Arnold, Dominik Djandji, Sarah Zahedi, Adelheid Cerwenka, Annette Paschen, Volker Schirrmacher, Frank Momburg
Publicat 2009Artigo -
9
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma per Cathrin Ritter, Kaiji Fan, Annette Paschen, Sine Reker Hardrup, Soldano Ferrone, Paul Nghiem, Selma Ugurel, David Schrama, Jürgen C. Becker
Publicat 2017Artigo -
10
Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function per Robert Michael Petri, Alexander Hackel, Katrin Hahnel, Claudia A. Dumitru, Kirsten Bruderek, Stefanie B. Flohé, Annette Paschen, Stephan Lang, Sven Brandau
Publicat 2017Artigo -
11
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma per Sheila López‐Cobo, Carmen Campos‐Silva, Amanda Moyano, Myriam Oliveira-Rodríguez, Annette Paschen, Marı́a Yáñez-Mó, María Carmen Blanco‐López, Mar Valés‐Gómez
Publicat 2018Artigo -
12
Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cells per Nicole Schwinn, Daria Vokhminova, Antje Sucker, Sonja Textor, Sandra Striegel, Iris Moll, Norman Nausch, Jochen Tuettenberg, Alexander Steinle, Adelheid Cerwenka, Dirk Schadendorf, Annette Paschen
Publicat 2008Artigo -
13
Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30 per Eva Schlecker, Nathalie Fiegler, Annette Arnold, Peter Altevogt, Stefan Rose‐John, Gerhard Moldenhauer, Antje Sucker, Annette Paschen, Elke Pogge von Strandmann, Sonja Textor, Adelheid Cerwenka
Publicat 2014Artigo -
14
Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids per Myriam Oliveira-Rodríguez, Sheila López‐Cobo, Hugh T. Reyburn, Agustín Costa‐García, Soraya López‐Martín, María Yáñez‐Mó, Eva Cernuda‐Morollón, Annette Paschen, Mar Valés‐Gómez, María Carmen Blanco‐López
Publicat 2016Artigo -
15
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B per Annette Paschen, Antje Sucker, Bettina Hill, Iris Moll, Marc Zapatka, Xuan Duc Nguyen, Geok Choo Sim, Isabelle Gutmann, Jessica C. Hassel, Jürgen C. Becker, Alexander Steinle, Dirk Schadendorf, Selma Ugurel
Publicat 2009Artigo -
16
Clinical and genetic analysis of melanomas arising in acral sites per Anne Zaremba, Rajmohan Murali, Philipp Jansen, Inga Möller, Antje Sucker, Annette Paschen, Lisa Zimmer, Elisabeth Livingstone, Titus J. Brinker, Eva Hadaschik, Cindy Franklin, Alexander Roesch, Selma Ugurel, Dirk Schadendorf, Klaus Griewank, Ioana Cosgarea
Publicat 2019Artigo -
17
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency per Fang Zhao, Antje Sucker, Susanne Horn, Christina Heeke, Nicola Bielefeld, Barbara Schrörs, Anne Bicker, Monika Lindemann, Alexander Roesch, Gustav Gaudernack, Mathias Stiller, Jürgen C. Becker, Volker Lennerz, Thomas Wölfel, Dirk Schadendorf, Klaus Griewank, Annette Paschen
Publicat 2016Artigo -
18
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma per Selma Ugurel, Dirk Schadendorf, Kai Horny, Antje Sucker, Sabine Schramm, Jochen Utikal, Claudia Pföhler, Rudolf Herbst, Bastian Schilling, Christian U. Blank, Jürgen C. Becker, Annette Paschen, Lisa Zimmer, Elisabeth Livingstone, Peter A. Horn, Vera Rebmann
Publicat 2020Artigo -
19
NF1 mutations in conjunctival melanoma per Simone L. Scholz, Ioana Cosgarea, Daniela Süßkind, Rajmohan Murali, Inga Möller, Henning Reis, Sonia Leonardelli, Bastian Schilling, Tobias Schimming, Eva Hadaschik, Cindy Franklin, Annette Paschen, Antje Sucker, K.–P. Steuhl, Dirk Schadendorf, Henrike Westekemper, Klaus Griewank
Publicat 2018Artigo -
20
Frequent <i>GNAQ, GNA11</i>, and <i>EIF1AX</i> Mutations in Iris Melanoma per Simone L. Scholz, Inga Möller, Henning Reis, Daniela Süßkind, Johannes A.P. van de Nes, Sonia Leonardelli, Bastian Schilling, Elisabeth Livingstone, Tobias Schimming, Annette Paschen, Antje Sucker, Rajmohan Murali, Klaus‐Peter Steuhl, Dirk Schadendorf, Henrike Westekemper, Klaus Griewank
Publicat 2017Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer research
Melanoma
Immunology
Genetics
Gene
Medicine
Biochemistry
Immune system
In vitro
Immunotherapy
Cancer
Cytotoxic T cell
Antigen
CD8
Cell biology
Internal medicine
NKG2D
T cell
Immune checkpoint
Oncology
Computational biology
Human leukocyte antigen
MHC class I
Mutation
Cell
Chemistry
Cytotoxicity
Major histocompatibility complex
Metastatic melanoma